Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Recruiting at 1 trial location
CK
Overseen ByCheryl Kefauver, RN
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: University of Southern California
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Research Team
AG
Amir Goldkorn, MD
Principal Investigator
University of Southern California
Eligibility Criteria
Inclusion Criteria
You are a male with metastatic prostate cancer set to commence systemic treatment, either for the first time or recurrently.
You are an adult male of any racial and ethnic background.
You may have previously taken part in clinical trials.
Treatment Details
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
Trials
956
Recruited
1,609,000+
National Cancer Institute (NCI)
Collaborator
Trials
14,080
Recruited
41,180,000+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.